Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
15.66
-0.28 (-1.76%)
Sep 9, 2026, 12:04 PM EDT - Market open
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $589.15 million as of September 9, 2026. Its market cap has increased by 98.58% in one year.
Market Cap
589.15M
Enterprise Value
359.17M
1-Year Change
98.58%
Ranking
Category
Stock Price
$15.66
ChartMarket Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $589.15M, an increase of 46.52%. That is a compound annual growth rate of 17.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 628.27M | 50.47% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 665.25M |
| Prime Medicine | 658.25M |
| CorMedix | 657.07M |
| Bright Minds Biosciences | 656.57M |
| Valneva SE | 651.26M |
| OmniAb | 629.54M |
| Arvinas | 613.98M |
| ProKidney | 607.67M |